41.72 0.00 (0.00%)
Pre-market: 6:18AM EDT
|Bid||41.16 x 3200|
|Ask||0.00 x 3100|
|Day's range||41.23 - 41.82|
|52-week range||32.99 - 44.63|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||295.89|
|Earnings date||27-Jul-2021 - 02-Aug-2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||49.04|
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Boston Scientific Corporation (NYSE: BSX).
Boston Scientific (BSX) registers strong sequential improvement in overall financial performance in Q1.
Boston Scientific (BSX) delivered earnings and revenue surprises of 23.33% and 5.30%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?